"We have translated Dr. Bob Weinberg's pioneering cancer stem cell research into clinical drug candidates, and Steve's insights and guidance will be a key to our future success." "Steve has a wealth of biopharmaceutical and drug development expertise," said Christoph Westphal, M.D., Ph.D., Chairman and CEO of Verastem.
http://www.businesswire.com/news/home/20130306005246/en/Stephen-Sherwin-M.D.-Joins-Verastem-Board-Directors
http://www.businesswire.com/news/home/20130306005246/en/Stephen-Sherwin-M.D.-Joins-Verastem-Board-Directors
No comments:
Post a Comment